CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
$19.12
arrow_downward
-0.21%(-0.040) 1D
$19.12
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 12, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
$19.22
High
$19.25
Low
$18.94
Mkt. cap
10.36T
Avg. vol.
304.28K
Volume
278.74K
52-wk high
$34.84
52-wk low
$18.94
Beta
0.56
Shares outstanding
3.36B
No. of employees
5K
Open
$19.22
High
$19.25
Low
$18.94
Mkt. cap
10.36T
Avg. vol.
304.28K
Volume
278.74K
52-wk high
$34.84
52-wk low
$18.94
Beta
0.56
Shares outstanding
3.36B
No. of employees
5K
News stories
From web sources and news partners
ad-hoc-news.de
·
28 minutes ago
Chugai reports Week 52 vamikibart data for Chugai Pharmaceutical stock
ad-hoc-news.de
·
1 hour ago
Chugai Pharmaceutical reports Week 52 vamikibart data: stock pre-market at EUR 34.84
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp